Anti-doping update, June 18, 2014
In accordance with Article 14.5 of the World Anti-Doping Code (the Code), WADA, acting as a central clearinghouse for Doping Control data, annually publishes statistical reports as reported by the WADA accredited laboratories in the Anti-Doping Administration and Management System (ADAMS).
WADA has made a number of enhancements to the 2013 report following an internal review, together with feedback received from stakeholders on the 2012 Testing Figures Report. These include:
• Sports are now listed along with their disciplines as entered in ADAMS;
• Sport testing figures are reported only for those sport/disciplines that are governed by the International Federation who is a signatory to the Code. This includes sports governed by Olympic IFs (including non-Olympic disciplines), IOC Recognised Federations, Non-IOC Recognised Federations, the IPC and other International Federations for athletes with an impairment; and
• The report has been split into a number of separate categories for stakeholders to easily select those specific testing figures of interest by summarizing Laboratory testing data from Urine, Blood and the Athlete Biological Passport samples.
These enhancements allow for a greater level of detail and accuracy, and make the report more user-friendly for those interested in reviewing global anti-doping activity.
We are pleased to provide you the 2013 WADA Anti-Doping Testing Figures.They are represented in four separate reports, namely Laboratory Report, Sport Report, Testing Authority Report and ABP Report-Blood Analysis, and include analyses by the 33 WADA accredited laboratories (in 2013) for in- and out–of-competition Urine, Blood and Blood Passport testing. These reports are provided to you in advance of public distribution, and WADA invites all ADOs to review their relevant testing data and to verify such data via ADAMS.
Furthermore, here is an ADAMS compilation reference tool which outlines the critical parameters of the ADAMS Laboratory Results Report functionality that may be used by ADOs to compile and verify their test results from ADAMS. ADOs are encouraged to use this tool in ADAMS to compile and review the AAFs (Adverse Analytical Findings) and ATFs (Atypical Findings) related to samples from their testing programs.
ADOs wishing to comment on the testing figures that are in the report and available in ADAMS should contact WADA at email@example.com. Please provide your comments by Monday, 23 June 2014.